Trial Profile
A phase I trial of biweekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 02 Jun 2016 New trial record